Burning Rock Biotech Limited
BNR
$2.90
-$0.04-1.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.52M | 17.97M | 17.50M | 17.50M | 16.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.52M | 17.97M | 17.50M | 17.50M | 16.77M |
| Cost of Revenue | 5.09M | 5.14M | 5.56M | 5.56M | 5.95M |
| Gross Profit | 12.43M | 12.83M | 11.94M | 11.94M | 10.82M |
| SG&A Expenses | 11.68M | 11.35M | 20.27M | 20.27M | 23.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.02M | 23.36M | 35.02M | 35.02M | 39.81M |
| Operating Income | -6.51M | -5.39M | -17.53M | -17.53M | -23.04M |
| Income Before Tax | -10.56M | -4.97M | -16.91M | -16.91M | -22.32M |
| Income Tax Expenses | 738.70K | 28.10K | 25.10K | 25.10K | 148.30K |
| Earnings from Continuing Operations | -11.30M | -4.99M | -16.93M | -16.93M | -22.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.30M | -4.99M | -16.93M | -16.93M | -22.47M |
| EBIT | -6.51M | -5.39M | -17.53M | -17.53M | -23.04M |
| EBITDA | -4.72M | -799.90K | -12.95M | -12.95M | -18.48M |
| EPS Basic | -10.93 | -4.84 | -16.51 | -16.51 | -21.94 |
| Normalized Basic EPS | -0.34 | -0.30 | -1.03 | -1.03 | -1.36 |
| EPS Diluted | -10.93 | -4.84 | -16.51 | -16.51 | -21.94 |
| Normalized Diluted EPS | -0.34 | -0.30 | -1.03 | -1.03 | -1.36 |
| Average Basic Shares Outstanding | 10.34M | 10.32M | 10.25M | 10.25M | 10.24M |
| Average Diluted Shares Outstanding | 1.03M | 1.03M | 1.03M | 1.03M | 1.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |